Status
Conditions
Treatments
About
The goal of this clinical trial is to test the safety and efficacy of a medical device in subjects with cerumen in excess. The main questions it aims to answer are:
Participants will use the device in each ear, once a day, every 3 days at home. Researchers will compare the medical device group to a control group who will not use the medical device.
Full description
Ocean Bio Actif Hygiène de l'oreille is a medical device class IIa indicated for the prevention of the formation of earwax plugs and consequently the pathologies linked to the accumulation of earwax (hearing loss and infection/affection of the external auditory canal).
This clinical investigation is designed to improve the quality and quantity of data available on both the safety and the efficacy of Ocean Bio-Actif, in order to confirm the safety and the efficacy of the product in a post-market environment.
The objective of the current clinical investigation is to confirm the efficacy and safety of topical application to the ear canal of Ocean Bio-Actif.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Gender: female and/or male.
Age:
30 to 40% having age between 3 to 12 yo, 30 to 40% between 13 to 65 yo, 30 to 40% more than 65 yo.
Subjects able to use the tested product.
Subjects having history of cerumen occlusion more than once a year with or without symptoms (reduction of hearing function, obstruction feeling of the ear canal,..).
Subjects having ear help system or regular users of systems such as anti-noise plugs or headsets (only for the 13yo subjects and more).
Subjects having a clinical score of ear canal obstruction of 2 or 3 at D0.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
99 participants in 2 patient groups
Loading...
Central trial contact
Caroline TANTER
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal